Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer

BACKGROUND: Biomarkers of therapeutic response and prognosis are needed to assist in the sequencing of treatments for metastatic castration-resistant prostate cancer (CRPC). Previously in a Phase 1 discovery study, we identified 14 circulating microRNAs that were associated with response to docetaxe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Br J Cancer
Hauptverfasser: Lin, Hui-Ming, Mahon, Kate L, Spielman, Calan, Gurney, Howard, Mallesara, Girish, Stockler, Martin R, Bastick, Patricia, Briscoe, Karen, Marx, Gavin, Swarbrick, Alexander, Horvath, Lisa G
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2017
Schlagworte:
Clinical Study
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5396108/
https://ncbi.nlm.nih.gov/pubmed/28278515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.50
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge